Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-17 · accession 0001567619-21-021059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-11-23 | 2021-11-17 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 436.7K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-17 | G | D | 10,000 | $0.00 | 436,684 | I By Trust | — | — | (F2) These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. |